K
Kirsten M. Williams
Researcher at Children's National Medical Center
Publications - 38
Citations - 4301
Kirsten M. Williams is an academic researcher from Children's National Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 13, co-authored 37 publications receiving 3759 citations.
Papers
More filters
Journal ArticleDOI
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
Madan Jagasia,Hildegard T. Greinix,Mukta Arora,Kirsten M. Williams,Daniel Wolff,Edward W. Cowen,Jeanne Palmer,Daniel J. Weisdorf,Nathaniel S. Treister,Guang-Shing Cheng,Holly Kerr,Pamela Stratton,Rafael F. Duarte,George B. McDonald,Yoshihiro Inamoto,Afonso Celso Vigorito,Sally Arai,Manuel B. Datiles,David A. Jacobsohn,Theo Heller,Carrie L. Kitko,Sandra A. Mitchell,Paul J. Martin,Howard M. Shulman,Roy S. Wu,Corey Cutler,Georgia B. Vogelsang,Stephanie J. Lee,Steven Z. Pavletic,Mary E.D. Flowers +29 more
TL;DR: In this article, the authors proposed a new clinical scoring system (0-3) that describes the extent and severity of chronic graft-versus-host disease for each organ or site at any given time, taking functional impact into account.
Journal ArticleDOI
T cell immune reconstitution following lymphodepletion.
TL;DR: Insight has permitted the manipulation of the immune system to maximize anti-tumor immunity through lymphopenia and led to an appreciation of mechanisms that underlie graft versus host disease.
Journal ArticleDOI
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
TL;DR: Improvements in survival will likely require early disease recognition, allowing for therapeutic modulation of disease prior to the development of irreversible airway obliteration, and reviews the epidemiology, pathogenesis, and available treatments.
Journal ArticleDOI
Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
TL;DR: The current understanding of the epidemiology and pathogenesis of BOS is described and information on evaluations and therapies for patients with BOS after HSCT is presented.
Journal ArticleDOI
Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
TL;DR: By expanding tumouricidal T cells, it may provide a venue to enhance T-cellular immunotherapy following transplantation and may impair long-term anti-tumour immunity and increase the likelihood of graft-versus-host disease.